Duvelisib

(Copiktra®)

Copiktra®

Drug updated on 11/16/2023

Dosage FormCapsule (oral; 15 mg, 25 mg)
Drug ClassKinase inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies.